Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;76(1):1-18.
doi: 10.1111/j.1399-0004.2009.01230.x.

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

H T Lynch  1 , P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland
Affiliations
Review

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

H T Lynch et al. Clin Genet. 2009 Jul.

Abstract

More than one million patients will manifest colorectal cancer (CRC) this year of which, conservatively, approximately 3% (approximately 30,700 cases) will have Lynch syndrome (LS), the most common hereditary CRC predisposing syndrome. Each case belongs to a family with clinical needs that require genetic counseling, DNA testing for mismatch repair genes (most frequently MLH1 or MSH2) and screening for CRC. Colonoscopy is mandated, given CRC's proximal occurrence (70-80% proximal to the splenic flexure). Due to its early age of onset (average 45 years of age), colonoscopy needs to start by age 25, and because of its accelerated carcinogenesis, it should be repeated every 1 to 2 years through age 40 and then annually thereafter. Should CRC occur, subtotal colectomy may be necessary, given the marked frequency of synchronous and metachronous CRC. Because 40-60% of female patients will manifest endometrial cancer, tailored management is essential. Additional extracolonic cancers include ovary, stomach, small bowel, pancreas, hepatobiliary tract, upper uroepithelial tract, brain (Turcot variant) and sebaceous adenomas/carcinomas (Muir-Torre variant). LS explains only 10-25% of familial CRC.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Circle graph depicting the marked genotypic and phenotypic heterogeneity in hereditary colorectal cancer syndromes. AC-I, Amsterdam Criteria I; MMR, mismatch repair; FAP, familial adenomatous polyposis; AFAP, attenuated familial adenomatous polyposis; HBCC, hereditary breast and colorectal cancer; PJS, Peutz–Jeghers syndrome; FJP, familial juvenile polyposis; CD, Cowden’s disease; BRRS, Bannayan–Ruvalcaba–Riley syndrome. (Revised with permission from Lynch et al. Cancer 2004;100:53–64).
Fig. 2
Fig. 2
Pedigree of a classical Lynch syndrome (LS) family showing colorectal cancer (CRC) as well as extracolonic cancers integral to the syndrome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. International Agency for Research on Cancer. Globocan 2002. 2008. [accessed on: 25 November 2008.]. Available at: http://www-dep.iarc.fr/
    1. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783–5788. - PMC - PubMed
    1. Bussey HJR. Familial polyposis coli: family studies, histopathology, differential diagnosis, and results of treatment. Baltimore, MD: Johns Hopkins University Press; 1975.
    1. Bülow S, Faurschou NT, Bülow C, et al. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis. 1996;11:88–91. - PubMed
    1. Aaltonen L, Johns L, Järvinen H, et al. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res. 2007;13:356–361. - PubMed

Publication types

MeSH terms